A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: Clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease

Archives of Internal Medicine

Volumn 163, Issue 10, 2003, Pages 1165-1171

  Allison, James E ^a,b   Hurley, Leo B ^a   Hiatt, Robert A ^a,b   Levin, Theodore R ^a,c   Ackerson, Lynn M ^a   Lieu, Tracy A ^d  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

^d HARVARD PILGRIM HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; PENICILLIN DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DYSPEPSIA; ENDOSCOPY; FEMALE; FOLLOW UP; HEALTH CARE COST; HELICOBACTER PYLORI; HUMAN; LONG TERM CARE; MALE; MANAGED CARE; NONHUMAN; OUTCOMES RESEARCH; PEPTIC ULCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; STOMACH ACID SECRETION; SYMPTOMATOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; CHI-SQUARE DISTRIBUTION; DRUG THERAPY, COMBINATION; FEMALE; HEALTH CARE COSTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; PEPTIC ULCER; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 0037568200     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.10.1165     Document Type: Article

References (27)

1. Lee J, O'Morain C. Who should be treated for Helicobacter pylori infection? a review of consensus conferences and guidelines. Gastroenterology. 1997;113(6 suppl):S99-S106.
2. Peterson WL, Fendrick AM, Cave DR, Peura DA, Garabedian-Ruffalo SM, Laine L. Helicobacter pylori-related disease: guidelines for testing and treatment. Arch Intern Med. 2000;160:1285-1291.
3. Fendrick AM, Chernew ME, Hirth RA, Bloom BS. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med. 1995;123:260-268.
4. Dooley CP, Cohen H, Fitzgibbons PL, et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med. 1989;321:1562-1566.
5. Sitas F, Forman D, Yarnell JW, et al. Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men. Gut. 1991;32:25-28.
6. Graham DY, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States: effect of age, race and socioeconomic status. Gastroenterology. 1991;100:1495-1501.
7. Kuipers EJ, Thijs JC, Festen HP. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther. 1995;9(suppl 2):59-69.
8. Bernersen B, Johnsen R, Bostad L, Straume B, Sommer AI, Burhol PG. Is Helicobacter pylori the cause of dyspepsia? BMJ. 1992;304:1276-1279.
9. Duggan A, Elliot C, Tolley K, Whynes D, Hawkey CJ, Logan RF. Randomised controlled trial of four dyspepsia management strategies in primary care with 12 months follow-up [abstract]. Gastroenterology. 2000;118(4, suppl 2, pt 1): A438.
10. Farkkila MA, Sarna S, Valtonen V, Sipponen P. "Test-and-treat" strategy for management of uninvestigated dyspepsia in primary healthcare [abstract]. Gastroenterology. 2000;118(4, suppl 2, pt 1):A438.
11. Chiba N, van Zanten SJ, Sinclair P, Ferguson RA, Escobedo SR. Beneficial effects of H. pylori eradication therapy on long term symptom relief in primary care patients with uninvestigated dyspepsia: the Cadet-HP Study [abstract]. Gastroenterology. 2000;118(4, suppl 2, pt 1):A438.
12. O'Connor HJ. Helicobacter pylori and dyspepsia: physicians' attitudes, clinical practice, and prescribing habits. Aliment Pharmacol Ther. 2002;16:487-496.
13. Krieger N. Overcoming the absence of socio-economic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82:703-710.
14. Levin TR, Schmittdiel JA, Kunz K, et al. Costs of acid-related disorders to a health maintenance organization. Am J Med. 1997;103:520-528.
15. Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res. 1998;7:75-83.
16. Blum AL, Talley NJ, O'Morain C, et al, and Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med. 1998;339:1875-1881.
17. Talley NJ, Vakil N, Ballard ED II, Fennerty MB. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med. 1999;341:1106-1111.
18. Talley NJ, Jannssens J, Lauritsen K, Rácz I, Bolling-Sternevald E, the Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow-up. BMJ. 1999;318:833-837.
19. Laine L, Schoenfeld P, Fennerty MB. Therapy for Helicobacter pylori in patients with nonulcer dyspepsia: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2001;134:361-369.
20. Jyotheeswaran S, Shah AN, Jin HO, Potter GD, Ona FV, Chey WY. Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified? Am J Gastroenterol. 1998;93:574-578.
21. Schubert M, DeWitt JM, Taylor CA. Prospective evaluation of the prevalence of H. pylori in duodenal and gastric ulcer: is its role overstated [abstract]? Gastroenterology. 1999;116(4, pt 2):A305.
22. Bruno JM, Jones MP, Kubik CM, Graettinger JK, Lambert RS. The low prevalence of Helicobacter pylori (Hp) in a military treatment facility population [abstract]. Gastroenterology. 1997;112(4, suppl):A79.
23. Di Battista R, Bierti L, Benassi R, et al. Prevalence and risk factors in Helicobacter pylori (HP) negative peptic ulcer in an area of Northern Italy [abstract]. Gastroenterology. 1997;112(4, suppl):A102.
24. Lassen AT, Pedersen FM, Bytzer P, Schaffalitzky de Muckadell OB. Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial. Lancet. 2000;356:455-460.
25. Talley NJ, Meineche-Schmidt V, Paré P, et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther. 1998;12:1055-1065.
26. Laine L, Fendrick AM. Helicobacter pylori and peptic ulcer disease: bridging the gap between knowledge and treatment. Postgrad Med. 1998;103:231-238, 243.
27. Vaira D, Holton J, Menegatti M, et al. Invasive and non-invasive tests for Helicobacter pylori infection. Aliment Pharmacol Ther. 2000;14(suppl 3):13-22.